Daily Newsletter

30 September 2024

Daily Newsletter

30 September 2024

Italian competition watchdog probes crisp firms over alleged price cartel

The investigation has already led to raids on the snack makers’ premises.

Andy Coyne

The Italian competition authority has launched an investigation into local crisp manufacturers Amica Chips and Pata over claims they coordinated prices.

Announcing the investigation, which has already led to raids on the companies’ premises, Autorita Garante della Concorrenza e del Mercato (AGCM) said the matter has been brought to its attention “thanks to the report of a whistleblower”.

In its statement, the AGCM said: “The two companies would have coordinated the price proposals to be presented to the large-scale retail chains for the sale, at a national level, of the chips produced.”

The watchdog said its investigation has been launched “for an alleged agreement restricting competition relating to the production and marketing of private-label chips produced on behalf of large-scale retail chains”.

Local media outlet Il Fatto Alimentare suggested the large-scale retail chains involved in this case would include Esselunga, Carrefour, Aldi and Lidl.

The AGCM added: “The two companies, according to the AGCM, would have coordinated to distribute customers among themselves, thus keeping prices at a supra-competitive level.”

The regulator said that, with the help of the Special Antitrust Unit of the Guardia di Finanza, it has carried out inspections at the main offices of the two firms, as well as another person “believed to be in possession of elements useful for the investigation”.

Just Food has asked Amica Chips and Pata for their response to the news of AGCM’s investigation.

APAC Consumer Health Overview

GlobalData's latest report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. Per our analysis, APAC region was the second-largest market in the industry in 2023, with value sales of $124.8 billion, and is forecast to record an increase in volume (million liters) during 2023–28, at a CAGR of 3.9%. The APAC consumer health industry was fragmented in 2023, with the top five companies accounting for a collective value share of ~10%, led by Amway.

APAC Consumer Health Overview

GlobalData's latest report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. Per our analysis, APAC region was the second-largest market in the industry in 2023, with value sales of $124.8 billion, and is forecast to record an increase in volume (million liters) during 2023–28, at a CAGR of 3.9%. The APAC consumer health industry was fragmented in 2023, with the top five companies accounting for a collective value share of ~10%, led by Amway.

APAC Consumer Health Overview

GlobalData's latest report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. Per our analysis, APAC region was the second-largest market in the industry in 2023, with value sales of $124.8 billion, and is forecast to record an increase in volume (million liters) during 2023–28, at a CAGR of 3.9%. The APAC consumer health industry was fragmented in 2023, with the top five companies accounting for a collective value share of ~10%, led by Amway.

APAC Consumer Health Overview

GlobalData's latest report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. Per our analysis, APAC region was the second-largest market in the industry in 2023, with value sales of $124.8 billion, and is forecast to record an increase in volume (million liters) during 2023–28, at a CAGR of 3.9%. The APAC consumer health industry was fragmented in 2023, with the top five companies accounting for a collective value share of ~10%, led by Amway.

APAC Consumer Health Overview

GlobalData's latest report brings together multiple data sources to provide a comprehensive overview of the Asia-Pacific consumer health industry, analyzing data from 26 countries in the region. Per our analysis, APAC region was the second-largest market in the industry in 2023, with value sales of $124.8 billion, and is forecast to record an increase in volume (million liters) during 2023–28, at a CAGR of 3.9%. The APAC consumer health industry was fragmented in 2023, with the top five companies accounting for a collective value share of ~10%, led by Amway.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close